The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer

Contralateral risk-reducing mastectomy (CRRM) rates have tripled over the last 2 decades. Reasons for this are multi-factorial, with those harbouring a pathogenic variant in the BRCA1/2 gene having the greatest survival benefit. On May 14th, 2013, Angelina Jolie shared the news of her bilateral risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Basu, Narendra Nath, Hodson, James, Chatterjee, Shaunak, Gandhi, Ashu, Wisely, Julie, Harvey, James, Highton, Lyndsey, Murphy, John, Barnes, Nicola, Johnson, Richard, Barr, Lester, Kirwan, Cliona C., Howell, Sacha, Baildam, Andrew D., Howell, Anthony, Evans, D. Gareth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854742/
https://www.ncbi.nlm.nih.gov/pubmed/33531640
http://dx.doi.org/10.1038/s41598-021-82654-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854742/
https://www.ncbi.nlm.nih.gov/pubmed/33531640
http://dx.doi.org/10.1038/s41598-021-82654-x

Ejemplares similares